glp-1 produced by Agonists - What is it? Glucagon-like peptide-1: Trends in Endocrinology

Fructose induces glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1 and insulin secretion: Role of adenosine triphosphate-sensitive K(+) channels

Manandhar B, Ahn JM

Adapting it thoughtfully to GLP-1s preserves access for athletes who need the drugs medically while creating a documentation pathway that addresses the performance-use concerns. Achari said hed also advise paying attention to the gray market for GLP-1s, which he says is enormous and largely invisible. Athletes obtaining research peptides from offshore sources are taking vastly different risks than those who are purchasing FDA-approved medications, including contamination, mislabelling, and inactive compounds

Post-transplant diabetes mellitus: causes, treatment, and impact on outcomes

Bogunovic M, Dav SH, Tilstra JS, Chang DT, Harpaz N, Xiong H, et al